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Abstract  
Purpose: Femoral nerve blocks (FNB) for anterior cruciate ligament reconstruction (ACLR) can 
effectively reduce post-operative pain, though this is tempered with the potential for quadriceps 
weakness, and subsequent concerns regarding impeded rehabilitation. The purpose of this 
retrospective study was to assess post-ACLR differences in International Knee Documentation 
Committee Subjective Knee Form (IKDC) scores in patients who did not (NB) and did (FB) 
receive perioperative FNB. 
 
Methods: A retrospective review was performed to identify all adults undergoing ACLR at 
Tripler Army Medical Center between January 2013 and August 2016, with International Knee 
Documentation Committee (IKDC) outcome scores from pre-surgery to 6-12 months post-
surgery. Patients were then divided into two groups, with the FB group being patients who 
received femoral nerve blocks (FNBs), and NB group patients not receiving a block. 
Demographics included age, sex, BMI, and ASA category.  IKDC scores were converted to 
normative values. Variables were analyzed using Mann-Whitney-U, ANCOVA, and Chi-square 
tests.  
 
Results: A total of 123 ACLR patients were identified with complete IKDC scores, of which 41 
did not receive a femoral nerve block. Preoperatively, IKDC scores were statistically similar 
between NB (Mean=40.82,SD=15.82) and FB groups (Mean=40.03,SD=15.36), (p=.79). There 
were no significant group differences in time-to-follow-up (p=.30), age (p=.74), or BMI (p=.11), 
gender (p=.27) or ASA category (p=.26). A repeated measures ANCOVA examined whether the 
treatment groups differed in IKDC score changes from pre-surgery to follow-up. Both groups 
had a significant increase in IKDC score from pre-surgery to follow-up (p<0.008).  However, 
there was no significant difference between groups (p<0.8) (Figure 2). 
 
Conclusion: This retrospective review of outcomes after ACLR surgery indicate knee 
functioning improvements after ACLR did not differ between patients who did and did not 
receive FNB. Future rigorous studies are needed to fully examine FNB effects on other patient-
reported and clinical outcomes after ACLR.  
 
Data Sources: PubMED, Cochrane Library, CINAHL, and Google Search 
 
Keywords: International Knee Documentation Committee, IKDC, anterior cruciate ligament, 
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Introduction 
Anterior cruciate ligament reconstruction (ACLR) surgery is a common orthopedic 
procedure most often performed in an outpatient setting.1 Patient satisfaction and outcomes are 
dependent on adequate pain control making pain management an important aspect of patient 
care. Femoral nerve blocks (FNBs) are an effective treatment for postoperative pain control in 
these patients as part of an anesthesia provider’s multimodal pain management plan.40 Peripheral 
nerve blocks may be avoided by surgeons, due to potential complications, or perceived 
inefficiency from potential delays related to block placement, onset, or failure.1  
Anterior cruciate ligament reconstruction is a painful surgical procedure. Femoral nerve 
blocks have been proven to be an effective pain management technique for ACLR surgery.6 
Peripheral nerve blocks have been shown to offer many benefits postoperatively to include: 
improved analgesia with decreased narcotic consumption, earlier ambulation, increased patient 
satisfaction, decreased length of stay, and a decrease in narcotic associated side effects.7 As with 
all modes of anesthesia, there are associated risks with peripheral nerve blocks including: 
infection, nerve injury and an increased fall risk due to quadriceps weakness.7  
ACL injuries and surgery can lead to deficits in motor function, muscular strength, 
muscle control, and range of motion.3 The International Knee Documentation Committee (IKDC) 
form is a patient self-reporting tool, used to measure quadriceps strength symmetry after ACLR.3 
This tool was developed to standardize orthopedic assessment of postoperative outcomes.4 
Literature shows the IKDC form to be a valid and reliable tool that has been adopted by the 
American Orthopaedic Society for Sports Medicine (AOSSM) for assessing function and 
mobility after ACLR.4,5  
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Gaps in current literature exist. There are studies that investigate muscle function after 
surgery with peripheral nerve blocks. However, there currently are no studies which investigate 
the relationship of FNB with long-term quadriceps muscle function using the IKDC form. The 
orthopedic department at Tripler Army Medical Center (TAMC) uses the IKDC form to evaluate 
quadriceps function in patients after ACLR surgery.  
Deficits in muscle function, strength, control, and range of motion are common after 
ACLR.3 It is critical for military personnel to return to pre-injury function quickly in order to 
return to duty. The patient population in this study consists primarily of soldiers who are required 
to function at full capacity in order to be able to carry out their military duties and return to the 
field. For this reason, it is imperative to provide the most optimal anesthesia care with the least 
amount of recovery or impact on long-term function.  
This study investigates the relationship of FNBs to persistent quadriceps muscle 
weakness using the International Knee Documentation Committee (IKDC) form. Information 
gained from this project will offer a foundation for future prospective studies involving nerve 
blocks and muscle function with the goal of optimizing return to function based on the IKDC 
form. The purpose of this project is to answer the question: Do patients undergoing anterior 
cruciate ligament reconstruction (ACLR) with a femoral nerve block (FNB), have persistent 
quadriceps muscle weakness, according to the International Knee Documentation Committee 
(IKDC) at six to twelve months postoperatively? 
Literature Review 
Transient quadriceps weakness is common after ACLR. Quadriceps impairment can 
affect gait, and may lead to pain, and fatigue. Many factors may contribute to weakness, and 
decreased motion including: type of procedure, length of time to surgery after injury, 
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preoperative motion, delayed or inadequate rehabilitation.31 ACL injuries and surgical 
procedures for repair, lead to deficiencies in function, muscular strength and control, and range 
of motion.3 In the first 12 months following surgery, only half of patients are able to return to a 
pre-injury level of function, and approximately 25% will reinjure their ACL.3  
Peripheral nerve blocks are an effective tool for post-operative pain management.32 
Opioids are not always sufficient in the immediate postoperative period. Significant pain may 
lead to a patient’s reluctance to move the extremity, which results in decreased participation in 
therapy.33 There is some controversy over whether or not femoral nerve blocks lead to long term 
quadriceps weakness, prolonging the return to a preoperative level of functioning. There is very 
little data regarding regional anesthesia and its long-term effect on muscle function 
postoperatively after ACLR surgery. 
ACL Reconstruction 
 ACL injury is one of the most commonly treated knee disorders with an estimated 
250,000 ACL injuries each year in the United States. Surgical intervention of ACL injuries is on 
the rise.3,20 For patients with anterior cruciate ligament deficiency and functional instability, 
ACL reconstruction surgery is the standard treatment.24 The goal of surgery is to restore 
functional stability of the knee to a preinjury level of function, and provide an expedient return to 
duty or sports activity.34  
Less than 50% of patients are able to return to their preinjury level of functioning within 
the first 12 months, 20-30% will develop a second ACL injury, and within 10 years over 50% 
will develop osteoarthritis.3 Patients undergoing subsequent ACL repair or revision have 
reported lower clinical outcome scores when compared to primary ACL reconstruction.21 
Younger patients, and athletes have an increased risk for ACL revision after a previous 
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injury.17,20 It is necessary for anesthesia practitioners to maximize patient recovery, while 
minimizing further complications, and risk for subsequent injury.3  
Several intrinsic and extrinsic risk factors for ACL injury have been identified including 
individual anatomy, genetic predisposition, and body mass index (BMI).21 Based on IKDC 
scores, studies have demonstrated positive outcomes for ACLR in children, adolescents, and 
adults over 40 years of age.21 There has been no significant difference in clinical outcomes 
associated with gender after ACLR.21 An increased baseline BMI is associated with decreased 
functional mobility, and increased complications after surgery, compared to patients with a 
normal BMI.21 There are no statistically significant differences in patient outcomes with early 
surgical intervention versus late intervention (<3 weeks post injury vs. >6 weeks post injury).21  
Surgical intervention is associated with better patient outcomes than medical 
management alone, however, IKDC scores do not show a statistically significant difference.21 
Clinical outcomes after ACLR, including rehabilitation compliance, knee pain and function, and 
return to sports time are improved if patients are optimistic, self-motivated, self-confident, have 
low stress, and have an adequate social support system.21 At five years postoperative ACLR, 
health-related quality of life is not associated with patient gender, age, or time from injury to 
surgery, however, health-related quality of life scores are reduced in patients who have severe 
osteoarthritis, have any injuries after ACLR, or require ACL revision surgery.21 Studies report 
that after ACLR, reductions in bone density did not normalize and were most substantial with 
decreased weight bearing, and immobility.21 There was no significant difference in bone density 
between patients treated surgically and those treated nonoperatively.21 Knee joint proprioception 
was decreased in individuals with ACL injuries, however, proprioception was improved after 
ACLR when compared to patients treated medically.21 
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Quadriceps Muscle Weakness 
 One of the most common persistent neuromuscular deficiencies correlated with ACLR is 
quadriceps muscle weakness, with strength deficits continuing to be greater than 20% at 6 
months postoperatively.8,22 Quadriceps impairment can affect gait, and may lead to pain, and 
fatigue. Many factors may contribute to weakness, and decreased motion including: type of 
procedure, length of time to surgery after injury, preoperative motion, and delayed or inadequate 
rehabilitation.31  
Transient quadriceps weakness is common after ACLR. The main goal of surgery is to 
return knee function to the preinjury level. ACL injuries and surgery lead to deficiencies in 
function, muscular strength and control, and range of motion.3 In the first 12 months following 
surgery, only half of patients are able to return to a pre-injury level of function, and 
approximately 25% will reinjure their ACL.3 Quadriceps muscle strength is a key variable for 
assessing clinical outcomes after ACL surgery and risks for re-injury of the affected knee.3 
Muscle weakness is more profound in ACL deficient knees than in reconstructed knees.21  
 In the past, it was hypothesized that exercise of the affected limb postoperatively could 
cause excessive strain on the ligament graft.22 Current evidence based practice recommends 
aggressive exercise and strengthening of the quadriceps muscle early in the postoperative period 
in order to facilitate recovery and optimize functional outcomes.22 Quadriceps weakness can be 
attributed to surgical site pain.37 Pain reduces mobility in the postoperative period, slowing 
recovery, and increasing complications associated with immobility, making pain management 
important for optimal recovery.  
 Loss of extension is common after ACL surgery, which may cause a patient to walk 
with a bent knee gait, placing pressure on the joint and strain on the quadriceps muscle, leading 
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to pain and muscle fatigue.31 Some common predictors of postoperative loss of extension are 
preoperative range of motion, surgical factors, and delayed rehabilitation.31 One study used the 
IKDC form to evaluate loss of extension (LOE) in patients four weeks after ACLR. Of the 
patients that had LOE at four weeks, 49% required arthroscopic debridement to recover motion 
in the affected knee.31 Preoperative knee extension and time to surgery were the major 
contributing factors to reduced range of motion after surgery. Patients with time to surgery after 
injury of 60 (median) days were more likely to experience LOE than patients at 93.5 (median) 
days, indicating that it is important to restore knee extension as much as possible prior to 
surgery.31 
Quadriceps muscle weakness is correlated with poor functional outcomes 
postoperatively, and is associated with early development of osteorthritis.8,22 Research suggests 
that muscular deficiencies may persist for years after surgery, and that weakness is often present 
in the contralateral limb following reconstruction.22 It is of great interest to the orthopedic 
specialty to identify factors which may contribute postoperative muscle weakness, and ways to 
facilitate the recovery process.22 For this reason it is important to research the long-term effect of 
peripheral nerve blocks on muscle function and recovery. 
IKDC Form 
Knee injuries often result in a necessity for surgical intervention, rehabilitation, and 
prevention of participation in sports or military duty, and are associated with an increased 
incidence of recurrent injury after a previous injury.17 The goal of treatment is to facilitate the 
return to duty or sports activity as quickly as possible. There are several instruments for 
evaluating knee function, but a standardized method of assessment is necessary for comparison 
of treatment outcomes and effectiveness.15,17 Evidence based practice requires measurement 
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tools to be well designed, well documented, high quality, reliable, valid and appropriate for the 
patient population being assessed.5,17,19  
In the 1980’s, due to the advent of new surgical procedures for anterior cruciate ligament 
(ACL) injuries, and the numerous mechanisms for evaluation of knee function, it was recognized 
that there was no standard method for assessing knee conditions.15 Empiric assessment often led 
to inaccurate interpretation of variables, and was generally subject to bias.15 Differences in 
assessment methods prohibited the ability to use the results of one scale to predict the outcomes 
on an alternate scale.15 An international committee of knee experts was formed in 1987 to create 
a standardized tool for evaluation of knee conditions, function and treatment outcomes.5,14,15 The 
International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form 
(Appendix A), was developed to standardize a method for measuring knee function in a variety 
of conditions.5,15 It  has been adopted and endorsed by many orthopedic associations including 
the American Orthopaedic Society for Sports Medicine (AOSSM).4,5,14  
Patient-oriented questionnaires are a meaningful mechanism for measuring clinical 
outcomes.19 These clinical outcome measures are designed to evaluate pain, function, and health 
status, and are useful in directing patient care.23 They have been shown to be beneficial for  
comparative effectiveness research, as well as, the comparison of institutional or provider 
quality.23 Patient-reported outcomes questionnaires specific to knee conditions focus on the 
major objectives of treatment, such as pain and other symptoms, function and activity level.23 
The validity, reliability and responsiveness of these instruments must be thoroughly and 
systematically evaluated.19 Responsiveness is a significant psychometric property of a clinical 
outcomes test, which offers the ability to detect a statistically significant change in the status of a 
patient.18 If a patient’s condition improves or deteriorates it will be reflected in a responsive 
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outcome measure.18  The IKDC is a patient-reported data collection instrument which has been 
extensively tested and proven to be a reliable, effective tool for assessing clinical outcomes. 
The International Knee Documentation Committee (IKDC) form is a self-administered 
questionnaire which uses simple language, appropriate for a general patient population, and 
measures symptoms (pain, edema, stiffness, catching, locking, and giving way), knee function, 
and sports activity.14,17 It is simple to administer in almost any clinical setting, and it functions 
similarly in both genders, various age groups, and patients with different diagnoses.3,19 The 
IKDC has been proven to be valid and reliable, and is associated with increased patient 
satisfaction scores.5,15 Studies have shown that the instrument has high convergent and divergent 
construct validity, as well as, content and structural validity.14,17 It is reported to have high test-
retest reliability, responsiveness, internal consistency, and interpretability with no ceiling or floor 
effects.4,14,17,18 The proven validity and reliability of this standardized patient-oriented outcome 
assessment tool, and the ease of its use, makes the IKDC form perfect for studies comparing 
treatment outcomes and effectiveness. 
 More recently a pediatric version of the IKDC has been developed, with wording 
modified to be more suitable to a pediatric population.23 It has been shown to be valid and 
reliable with psychometric properties adequate for pediatric ages ranging from 10 to 18 years.23 
However, in adolescent patients aged 13 to 17 years, there is no clinically significant difference 
between the scores on pediatric, and adult IKDC forms, allowing for the use of the form that is 
most practical for long-term tracking of patient treatment, and outcomes.23 In this age group, the 
scores of both versions of the IKDC form can reliably be converted between the two, because 
they are highly correlated.23  The International Knee Documentation Committee form is an 
effective tool for assessing quadriceps strength after ACLR and using the data to determine when 
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a patient is ready to return to work, sports, or military duty. Clinicians can use the form to 
evaluate quadriceps strength and decide when they feel it is safe for patients to return to their 
previous level of physical activity.34  
Peripheral Nerve Blocks 
 Postoperative pain control is an important aspect of anesthetic management and patient 
care.  Patient satisfaction and outcomes are heavily dependent on adequate pain control.1 For 
patients receiving orthopedic surgery, a peripheral nerve block (PNB) can be an effective 
treatment for postoperative pain as part of a multimodal anesthetic plan. PNBs block the pain 
impulses along the nerves that supply the extremity which leads to a decrease in the use of 
narcotics and other anesthetics.13 This in turn leads to a reduction in the side effects associated 
with narcotics such as nausea and vomiting, prolonged sedation, or respiratory depression.31 
Reduced anesthetic and narcotic consumption are associated with shorter hospital stays, quicker 
recovery, fewer hospital admissions, reduced healthcare costs, and increased patient satisfaction.1 
History 
In 1853, Alexander Wood came up with the idea of producing nerve blockade by nerve 
injection. He attempted to treat neuralgia by injecting morphine close to the nerve of the affected 
area.38 Carl Koller discovered the use of cocaine to numb the conjunctiva for eye surgery in 
1884. By 1885, William Halsted and Richard Hall had demonstrated the effectiveness of 
blocking peripheral nerves with cocaine.38 However, the use of cocaine for regional anesthesia 
was limited by its toxicity, difficulty to sterilize, brief duration and potential for addiction. In 
1904, Einhorn developed procaine which was low in toxicity, and high in stability but it had a 
short duration of action and a potential to induce allergic reactions.38 In 1943, Nils Lofgren 
developed lidocaine and from this, derivatives were developed. The advantage of local 
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anesthetics is that they are potent, predictable, heat resistant, and rarely cause allergic reactions. 
It is lidocaine and the derivatives mepivacaine, prilocaine, bupivacaine and ropivacaine that are 
used today to provide safe and effective nerve blockade for postoperative surgical pain 
management.38 
Benefits 
Peripheral nerve blocks (PNB) are used routinely in orthopedic surgery for perioperative 
pain management. They provide postoperative analgesia and reduce anesthetic requirements 
intraoperatively. PNBs can be safely administered using nerve stimulation, or ultrasound 
guidance, as a single shot injection, or continuously through a catheter. Improved perioperative 
pain control is associated with earlier mobilization of the extremity, quicker recovery, reduced 
length of hospital stay, decreased expense, and increased patient satisfaction.25 It is important for 
postoperative orthopedic patients to begin ambulation, rehabilitation and physical therapy 
early.24 Patients who begin ambulation and therapy early in the postoperative period experience 
less deep vein thrombosis formation, decreased length of hospital stays and a reduction in 
hospital costs.26  
Peripheral nerve blocks are associated with decreased PACU stay, decreased need for 
narcotics, and a decreased incidence of postoperative nausea and vomiting (PONV).27 Reducing 
postoperative pain reduces morbidity, increases functional recovery, hastens discharge from the 
hospital, and may reduce the development of chronic postoperative pain.27 Nerve blocks provide 
a superior level of analgesia as compared to using an opioid analgesic method alone.24 PONV, 
hypotension, and apnea are associated with opiates and can potentially lead to increased 
morbidity and mortality, especially in older patients.26 PNBs provide effective analgesia while 
significantly reducing opioid consumption, and the risk of apnea associated with opioid use.  
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Complications 
Peripheral nerve blocks are safe and effective for postoperative pain control as part of the 
anesthetic plan. As with any type of anesthetic, there are risks and benefits associated with 
PNBs. When preparing an anesthetic plan, the anesthesia provider must carefully weigh the risks 
and benefits of the types of anesthesia with the patient’s comorbidities, in order to formulate the 
safest plan of care for each patient.  
Complications associated with PNBs include hematoma from injury to adjacent blood 
vessels, nerve damage from inadvertent injection directly into the nerve, toxicity from 
intravascular injection of local anesthetic, and injury of adjacent structures.28 Although, these 
complications are extremely rare they can potentially be very serious. Relatively large amounts 
of local anesthetic are used for PNB which can contribute to local anesthetic systemic toxicity. 
Preventive measures can be taken to reduce the risk of toxicity such as incremental injections 
with aspiration, test doses, dose limitation, and intravascular markers such as epinephrine which 
constricts nearby blood vessels reducing the amount of uptake into the vascular system.29 Lack of 
motor and sensory function of the blocked extremity can also lead to inadvertent injuries to the 
limb or falls.   
Technique 
The electrical nerve stimulator has been the gold standard for placing peripheral nerve 
blocks for years but with developments in ultrasound (US) technology, US is becoming more 
popular.36 The ability to visualize the nerves and the surrounding structures make it easier to 
avoid complications such as inadvertent intraneural or intravascular injection. Ultrasound 
guidance offers benefits such as faster onset times, prolonged analgesia, better block quality, and 
decreased need for rescue analgesia.29  Less local anesthetic is required when ultrasound is 
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utilized, which decreases the incidence of local anesthetic systemic toxicity that may occur with 
intravascular injection or absorption.29 Ultrasound utilization allows the practitioner to visualize 
the needle trajectory to avoid nearby blood vessels and other sensitive surrounding tissues.35 
Ultrasound offers the ability to visualize the spread of local anesthetic around the nerve for a 
more successful nerve block. There is no statistically significant difference in the already low 
rates of neurological complications between techniques that use ultrasound or peripheral nerve 
stimulators to place blocks.36   
Femoral Nerve Block 
 Femoral nerve blocks have been the standard for regional anesthesia for postoperative 
pain management following knee surgery for decades.24 They are commonly used with general 
anesthesia as part of a multimodal anesthetic plan of care, and are shown to effectively treat 
perioperative pain while decreasing anesthetic and narcotic requirements, reducing anesthesia 
associated side effects, and increasing patient satisfaction.1 Femoral nerve blocks offer improved 
analgesia when compared to opioid analgesia.24 The superior analgesia demonstrated by FNBs 
results in a decrease in narcotic consumption and narcotic associated side effects.24 High narcotic 
requirements are associated with an increased incidence of nausea and vomiting, increased 
recovery times, unplanned admissions to the hospital and a resulting increase in healthcare 
costs.24  
 One study looked at quadriceps strength and function at six months after ACLR in 
patients that received a continuous femoral nerve block.9 In this retrospective study, patients 
received femoral nerve blockade continuously for 48 hours postoperatively through a peripheral 
nerve catheter for pain management.9 Functional tests were administered by a physical therapist  
six months after surgery to evaluate quadriceps strength and function.9 Time to return to sport 
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was determined by full clearance for return to activity by the surgeon.9 It was concluded that at 
six months there was inferior quadriceps strength and function in the nerve block group, but 
there was no significant difference in time to return to sports, bringing into question the clinical 
significance of the decreased muscle strength.9  
 Another study investigated strength deficits in adolescent patients at six months after 
ACLR with FNBs.10 At six months postoperatively, patients under the age of 18 underwent 
strength and functional testing at which time the surgeon made the decision for clearance for 
return to sports activity.10 The study concluded that the adolescent patients in the FNB group had 
significant deficiencies in knee extension and flexion strength when compared to the control 
group, and that patients who did not receive a block were on average five times more likely to 
meet criteria to be cleared for sports.10    
 A study using the IKDC form to evaluate loss of extension (LOE), in patients four weeks 
after ACLR, investigated FNB for analgesia as a possible contributing factor of LOE. Loss of 
extension is a common knee motion deficit after ACLR surgery, which may produce a bent knee 
gait, placing pressure on the joint and strain on the quadriceps muscle, leading to pain and 
muscle fatigue.31 Researchers found no correlation between FNB and LOE in this study, or a 
subsequent study using single-shot and continuous FNB when compared to placebo.31 It was 
discovered that preoperative knee extension and time to surgery were the major contributing 
factors of decreased range of motion after ACLR, and that it is most important to restore as much 
knee extension as possible prior to surgery.31 
Saphenous Nerve Block 
 Femoral nerve blocks are an effective part of the multimodal anesthetic plan, with 
patients demonstrating a decrease in opioid consumption, and decreased visual analog scale 
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(VAS) pain scores in the first 24 hours of the postoperative period.6 However, a postoperative 
decrease in quadriceps muscle strength associated with FNBs, may create an increased risk for 
falls or other injuries in the first 24 hours after surgery.6 This risk has led to a search for a 
treatment that is as effective at treating postoperative pain as an FNB, while maintaining 
quadriceps strength and function.  
With the current use of ultrasound technology for peripheral nerve blocks, it is easier to 
block the saphenous nerve in the anteromedial thigh safely and successfully.6 It is difficult to 
achieve complete pain relief with one nerve block, due to the many branches of nerves 
innervating the knee.6 Patient satisfaction scores favor FNB, however, there is no difference in 
the occurrence of adverse effects.6 The femoral nerve block provides superior postoperative 
analgesia, however, the saphenous nerve block causes less quadriceps muscle blockade in the 
immediate postoperative period.6 The initial ACL injury is more likely to cause quadriceps 
muscle weakness than the peripheral nerve block.6 There are no studies comparing the long-term 
effects of saphenous nerve blocks versus femoral, on quadriceps function.  
Adductor Canal Block 
 Ambulating patients early after surgery is important for decreasing postoperative 
morbidity, and hastening the recovery process, to include function and mobility. Pain and muscle 
weakness are the two main limiting factors for early ambulation, however, improving one factor 
generally diminishes the other.24 Femoral nerve block is a standard treatment for postoperative 
pain control after ACLR. Studies show that femoral nerve blocks provide superior analgesia 
compared to only opioids, but with fewer side effects.24 However, quadriceps weakness 
postoperatively places patients at higher risks for falls.11,12,13 Studies have investigated adductor 
canal blocks (ACBs) as an alternative to FNBs for postoperative pain management, due to the 
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potential for quadriceps muscle sparing, and a reduction of the risks associated with decreased 
motor function. This is accomplished by blocking the distal branches of the femoral nerve in the 
mid-thigh.37 Compared to the FNB, the ACB primarily affects sensory nerves.  
One study compared FNB to ACB for management of pain after ACL reconstruction.24 
Visual analog scale (VAS), morphine consumption, and muscle strength were assessed 
postoperatively and every six hours for 24 hours.24 Patients that received FNB had lower VAS 
scores, less morphine requirements, but more quadriceps muscle weakness than the ACB 
group.24 Two studies compared quadriceps strength of healthy volunteers without surgery after 
FNB and ACB.11,12 Both studies demonstrated a greater reduction in quadriceps strength in the 
FNB group compared to the ACB group. In one of the two studies, the ACB group exhibited 
only an 8% reduction in muscle strength from baseline, and may be related to the effect of the 
anesthetic on the vastus medialis muscle which traverses the adductor canal.11 The FNB group 
averaged a 49% decrease compared to baseline.11 However, these studies were unable to 
compare analgesic effect between the two groups since the study populations were healthy 
volunteers and not surgical patients. There is muscle sparing with an adductor block when 
compared to FNB in the immediate postoperative period, but there are no long-term studies 
investigating muscle function with adductor block.11,12  
Systematic Review 
 A systematic review of six studies, compared outcomes of patients that received FNB 
with outcomes of patients that did not receive FNB for ACLR.41 Two studies examined the early 
postoperative period (within 12 weeks), and found no significant difference between patients 
who received FNBs and those that did not.41 One study found significant deficits in the nerve 
block group at 6 weeks postoperatively, which were no longer apparent at 6 months.41 The other 
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three studies examined patient outcomes at 6 months with conflicting results, none of which 
appear to have any clinical significance. None of the six studies used IKDC scores to measure 
functional outcomes. 
Conclusion 
Anterior cruciate ligament reconstruction is a common surgical procedure for repair of 
ACL rupture. ACL injury and surgery result in decreased knee function and quadriceps muscle 
weakness. The IKDC form is a patient self-reporting tool, which was developed to standardize 
orthopedic assessment of postoperative outcomes. It is a reliable, validated tool that has been 
adopted by many orthopedic associations for assessing function and mobility after ACLR. 
Literature demonstrates that FNBs effectively treat perioperative pain while decreasing 
anesthetic and narcotic requirements, reducing anesthesia associated side effects, and increasing 
patient satisfaction, with minimal risk of complications. There is some controversy over the 
contribution of femoral nerve blocks on to quadriceps weakness. There are studies that 
investigate muscle function after surgery with peripheral nerve blocks. However, there currently 
are no studies which investigate the relationship of FNB with long-term quadriceps muscle 
function using the IKDC form.  
The purpose of this study was to investigate the relationship of FNBs to persistent 
quadriceps muscle weakness, using the (IKDC) form. Research of this nature will provide a basis 
for future studies utilizing the IKDC form to explore the relationship between nerve blocks and 
muscle function, with the goal of optimizing the return to a preoperative level of function. This 
retrospective study was intended to answer the question: Do patients undergoing anterior cruciate 
ligament reconstruction (ACLR) with a femoral nerve block (FNB), have persistent quadriceps 
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muscle weakness, according to the International Knee Documentation Committee (IKDC) from 
six to twelve months postoperatively? 
Methods and Materials 
An extensive literature review was performed for this study. Current literature agrees that 
FNBs are effective for perioperative pain control while reducing narcotic consumption and 
associated risks. There is limited data regarding long term effects associated with FNBs, and 
available data is inconclusive. There are no studies using the IKDC form to evaluate effects of 
FNB on muscle function after ACLR at 6 to 12 months postoperatively. 
This study was performed, as illustrated in figure 1, at Tripler Army Medical Center 
(TAMC) with cooperation from the orthopedic and anesthetic departments. IKDC data was 
collected from the orthopedic department to identify patients for the study. The anesthetic 
records for the identified patients were recovered from the archives to identify the patients who 
received an ultrasound guided FNB, and which patients did not. The study participants were then 
divided into two groups. Group FB are patients who received an FNB and group NB are patients 
who did not receive a block. The two groups were compared to determine if there is a 
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Socrates© (Standardised Orthopaedic Clinical Research and Treatment Evaluation 
Software) is a computer software program, which has been approved for use at TAMC for data 
collection/storage, tracking patient outcomes, conducting research, and quality 
assurance/performance improvement. It is a patient reported outcome database registry that 
houses information regarding outcome measures, to include IKDC data. The registry is a HIPAA 
compliant, password protected software program which is installed within the TAMC firewall on 
TAMC servers. The orthopedic department at TAMC has been collecting data using this 
electronic platform since 2013. The contract with Socrates© includes the use of the IKDC form 
(Appendix A) and the IKDC is a validated outcome score approved for use within the TAMC 
system. Essentris© is a password protected medical database which stores medical records, 
including anesthetic records. It is also installed on the TAMC servers and within the firewall. 
Study Design 
A retrospective review of existing data from the orthopedic registry was performed to 
identify all patients who had an ACLR between January 1, 2013 and August 31, 2016, and have 
IKDC outcome scores with a 6-12 month follow-up. The electronic medical records were then 
reviewed for the type of anesthetics administered, and the patients were then divided into two 
groups: group FB (patients who received FNBs) and group NB (patients who did not receive 
FNBs). Each patient record was identified, reviewed, and compiled individually by hand due to 
the lack of a computer program or database available for identification of types of anesthesia 
received by patients. All data was combined onto one excel spreadsheet and de-identified at the 
time of analysis. Any links to patient identifiers were destroyed. Only the study team had access 
to the data, and the data collection sheet was kept on a password-protected spreadsheet, with 
access via Common Access Card© (CAC) enabled computers. The CAC© is a smart card used by 
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the military to protect the security of sensitive and confidential information on military 
computers and servers.  
 The retrospective design of this study was similar to that of Krych et al,9 in which they 
observed quadriceps strength and function at six months after ACLR in patients that received 
femoral nerve blockade continuously for 48 hours postoperatively, through a peripheral nerve 
catheter.9 Functional tests were administered at six months postoperatively to evaluate 
quadriceps strength and function.9 It was concluded that at six months there was inferior 
quadriceps strength in the nerve block group, but the results were not clinically significant.9  The 
IKDC form was not used in this study for the assessment of muscle strength and function.   
Setting 
This study was performed at Tripler Army Medical Center (TAMC) with cooperation 
from the orthopedic and anesthetic departments. Orthopedic and anesthetic data had previously 
been collected and stored routinely as necessary for documentation of patient care. The 
appropriate population was identified, and the data was reviewed, compiled, and analyzed. The 
only cost associated with this study was consistent with lost wages associated with cost of the 
researchers’ time. 
Ethics 
Data was kept on a password-protected spreadsheet accessed via CAC© enabled 
computers and only available to investigators.  Identifying information collected included name 
and date of surgery.  This was kept on a separate spreadsheet and each patient assigned a unique, 
non-identifying alphanumeric code.  The main datasheet contained only the alphanumeric code, 
and did not include personally identifiable information.  Once all data had been collected, the 
link between the names and alphanumeric code was deleted. IRB approval was obtained through 
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the University of Michigan Flint (Appendix B). As a retrospective review of existing data, this 
study qualified as a performance improvement (PI) project (Appendix C) through TAMC, and 
was exempt from IRB submission. 
Population 
A retrospective chart audit was performed to identify all patients, 18 years and older, at 
TAMC who underwent ACLR between January 1, 2013 and August 31, 2016, and have IKDC 
outcome scores in the Socrates© database, with follow-up 6-12 months postoperatively. This 
convenience sample consisted of a total sample size of 123 patients, 82 who received a FNB for 
surgery, and 41 who did not receive FNB. Demographics included age, sex, body mass index 
(BMI), American Society of Anesthesiology (ASA) physical status, and tobacco use. Inclusion 
criteria were: unilateral ACLR, preoperative and 6-12 month postoperative IKDC scores, and 18 
years of age and older.   
Subjects were excluded from the analysis if they had bilateral ACL 
injuries/reconstructions, multiple ligament reconstructions, no preoperative or 6-12 month 
postoperative IKDC scores, or under age 18 at the time of surgery. Concomitant meniscus or 
cartilage surgery at the time of ACLR were not grounds for exclusion. IKDC scores were 
converted to normative values. Variables were analyzed using Mann-Whitney-U, ANCOVA, and 
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Table 1. Demographic and Clinical Differences Between Patients who did not (NB) and did 







Male, n (%) 35 (85%) 63 (64%) 
Pearson Chi-Square = 
1.23 (p=.27) 
Current tobacco use, 
n (%) 
10 (24%) 25 (31%) 
Pearson Chi-Square = 
.00 (p=1.00) 
Age, median years 
[IQR] 
28 [25, 35] 29 [24, 35] 
Mann-Whitney 
U=1618 (p=.74) 
ACLR Revision, n 
(%) 
4 (10%) 10 (12%) 
Pearson Chi-Square = 
.16 (p=.69) 
Other perioperative 
block, n (%)  
3 (7%) 36 (44%) 
Pearson Chi-Square = 
16.87 (p<.001) 
Autograft, n (%) 18 (45%) 26 (32%) 
Pearson Chi-Square = 
2.06 (p=.15) 
ASA Physical Status 
1, n (%) 
14 (34%) 33 (40%) 
Pearson Chi-Square = 
.43 (p=.51) 
BMI [IQR] 28.18 [25.76, 31.33] 26.71 [24.85, 29.93] 
Mann-Whitney 
U=1347 (p=.11) 
Note: All patients had an ASA Physical Status of 1 or 2, except one patient had an ASA 3. 
   
Implementation 
 After the study was approved by TAMC and the University of Michigan Flint (UMF), 
patients who had undergone ACLR between January 1, 2013 and August 31, 2016 were 
identified from the surgical scheduling database. Once these patients were identified, the IKDC 
data was obtained from the orthopedic department using the Socrates© database. Once this list of 
patients was finalized, the anesthetic records were accessed using Essentris,© to identify which 
patients received FNBs and which did not.  
The following demographic information was recorded: age, sex, gender, American 
Society of Anesthesiology (ASA) physical status, body mass index (BMI), and tobacco use 
(table 1). Other data collected included allograft versus autograft, if the patient received another 
perioperative block with the FNB, and whether the ACLR was a primary surgery or a revision 
(table 1). The data was then de-identified, the patients were assigned alpha-numeric codes, and 
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all patient identifiers were destroyed. All data was accessed and stored on a computer at TAMC 
which is encrypted and password protected. Any data which contained patient identifiers 
incorporated a second level of encryption and password protection. All standards were 
maintained per TAMC policy to protect patient data. 
Results 
In this retrospective study, 123 ACLR patients with completed IKDC scores were 
identified, of which 82 received a femoral nerve block and 41 did not. Preoperatively, IKDC 
scores were statistically similar between NB (Mean=40.82, SD=15.82) and FB groups 
(Mean=40.03, SD=15.36), (p=.79). There were no significant group differences in time-to-
follow-up (p=.30), age (p=.74), or BMI (p=.11) by means of Independent Samples Mann-
Whitney U tests. Chi-square tests indicate there were no significant distribution differences 
between groups for gender (p=.27) or ASA category (p=.26).  
Outlier tests indicated two patients had BMI values that were extreme and these values 
were substituted using Tukey’s Hinges (1.5* Tukey Hinge range + 75th percentile value). A 
repeated measures ANCOVA examined whether the treatment groups differed in IKDC score 
changes from pre-surgery to follow-up. To control for any variance in IKDC score changes 
attributed to time-to-follow-up, it was included as a covariate in the model. There was a 
significant effect of time (p<0.008), such that both groups had a significant increase in IKDC 
score from pre-surgery to follow-up. However, the treatment group x time interaction was not 
significant (p<.80), indicating that both groups had similar IKDC score improvements from pre-
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Both groups were similar across all clinical and demographic characteristics. After 
controlling for graft type, additional type of regional block, current tobacco use, and pre-surgical 
IKDC, covariate-adjusted generalized linear model (GLM) results indicated no significant 
difference between NB (M=21.13, SE= 3.05) and FB+ (M=21.18, SE=2.07) IKDC change scores 
[B=-.05 (95%CI -7.53, 7.43), p=.99].  
IKDC Scores 
 The IKDC form is a validated instrument used for patients with knee disorders to assess 
function, symptoms, and sports activity.5 The form is endorsed by the American Academy of 
Orthopaedic Surgeons (AAOS) as a patient reported outcome measures instrument specifically 
for ACL related assessment.42 The IKDC form is administered preoperatively and 
















No Block Femoral Block
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results of the form (Appendix A) are scored by summing the scores for each item. An ordinal 
method is used to score the response to each item. A score of 0 is given to responses representing 
the lowest level of function, or the highest level of symptoms. The scores for each item are 
summed and divided by the maximum score which is 87. The total score is then transformed to a 
scale that ranges from 0 to 100.  
IKDC Score = [
𝑆𝑢𝑚 𝑜𝑓 𝐼𝑡𝑒𝑚𝑠
𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑃𝑜𝑠𝑠𝑖𝑏𝑙𝑒 𝑆𝑐𝑜𝑟𝑒
] 𝑥 100 
The transformed score represents a measure of function. Higher scores indicate higher 
levels of function and lower levels of symptoms. For example, a score of 100 would be 
interpreted to mean no limitation with activities, and the absence of symptoms. The scores in 
figure 2 indicate the improvement in scores from preoperatively to 6 to 12 months 
postoperatively. The lower preoperative scores indicate the level of function and symptoms with 
the ACL injury prior to surgery, and the higher postoperative scores indicate the improvement in 
function after surgery (Figure 2). The scores in figure 2 are normalized for age and gender using 
the normative data produced by Anderson et al5 for the International Knee Documentation 
Committee. 
Discussion 
 Femoral nerve blocks for ACLR can effectively reduce post-operative pain, though this is 
tempered with the potential for quadriceps weakness, and subsequent concerns regarding 
impeded rehabilitation. The goal of the present retrospective study was to assess post-ACLR 
differences in IKDC scores in patients who did, or did not receive perioperative FNB. Both 
groups showed similar improvements in IKDC scores from pre-surgery to follow-up, indicating 
no statistical difference between the groups. There were no differences in scores with regards to 
age, gender, BMI, ASA physical status, tobacco use, time to follow-up, graft type, or the addition 
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of a second nerve block. The implications of this study serve to give piece of mind to anesthesia 
providers and surgeons alike, that postoperative pain for patients undergoing ACLR can be 
safely, and effectively managed with FNBs. This is this first study of this type that utilizes the 
IKDC score to investigate patient outcomes associated with the use of FNB for postoperative 
pain management associated with ACLR. 
Study Limitations 
 This study was performed at a single military medical center, and the results may not be 
generalizable. The patient population predominately consisted of young, healthy, males, ASA 
physical status 1 and 2, active duty military members. Pediatric patients were not represented in 
this sample. The retrospective design of this study allows for the influence of other potential 
variables due the lack of randomization.  
Recommendations for Future Research 
 Future research including a larger multicenter study within the military medical system is 
recommended, with a prospective randomized control design, or at a civilian hospital for 
generalizability. A patient population with a representative sample of ASA physical status 1-4, 
including elderly patients, and an equal gender pool should be included. This research provides a 
basis for future studies to utilize the IKDC form to explore the relationship between nerve blocks 
and muscle function, with the goal of optimizing the return to a preoperative level of function. 
Dissemination 
The results were shared as a lecture with approximately forty people at the weekly lecture 
series meeting including the Tripler Army Medical Center anesthesia department, the United 
States Army Graduate Program in Anesthesia Nursing/Northeastern University students, and 
Uniform Services University of Health Sciences medical students and residents. An abstract has 
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been submitted, in collaboration with the orthopedic department, to the American Academy of 
Pain Medicine (AAPM) for a poster presentation at the AAPM 34th Annual Meeting in April 
2018. An electronic manuscript will be prepared for submission to a peer reviewed journal, 
according to the journal guidelines. The results of this study are currently being used by the pain 
service at TAMC to support the use of FNBs for pain management for ACLR surgery. 
Conclusion 
Literature demonstrates that FNBs are effective in the management of perioperative pain. 
They decrease anesthetic and narcotic requirements, reduce anesthesia associated side effects, 
and increase patient satisfaction, with minimal risk of complications. However, there remains 
some controversy over the contribution of femoral nerve blocks on quadriceps weakness. The 
IKDC form is a patient self-reporting tool with proven reliability, and validity for assessing 
function and mobility after ACLR, making it the ideal tool for assessing patient outcomes 
associated with FNB.  
The purpose of this study was to investigate the relationship of FNBs to persistent 
quadriceps muscle weakness, using the (IKDC) form, effectively answering the question: Do 
patients undergoing anterior cruciate ligament reconstruction (ACLR) with a femoral nerve 
block (FNB), have persistent quadriceps muscle weakness, according to the International Knee 
Documentation Committee (IKDC) from six to twelve months postoperatively? 
This retrospective review of outcomes after ACLR surgery indicates knee functioning 
improvements after ACLR did not differ between patients who did and did not receive FNB. 
Future rigorous studies are needed to fully examine FNB effects on other patient-reported and 
clinical outcomes after ACLR.  
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Appendix A 




Grade symptoms at the highest activity level at which you think you could function without 
significant symptoms, even if you are not actually performing activities at this level. 
1. What is the highest level of activity that you can perform without significant knee pain? 
 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework or yard work 
Unable to perform any of the above activities due to knee pain 
2. During the past 4 weeks, or since your injury, how often have you had pain? 
 0 1 2 3 4 5 6 7 8 9 10 
Never            Constant 
3. If you have pain, how severe is it? 
   0 1 2 3 4 5 6 7 8 9 10 
No pain             Worst pain  
4. During the past 4 weeks, or since your injury, how stiff or swollen was your knee? 





5. What is the highest level of activity you can perform without significant swelling in your 
knee? 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework, or yard work 
Unable to perform any of the above activities due to knee swelling 
6. During the past 4 weeks, or since your injury, did your knee lock or catch? 
Yes     No 
7. What is the highest level of activity you can perform without significant giving way in your 
knee? 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework or yard work 
Unable to perform any of the above activities due to giving way of the knee 
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SPORTS ACTIVITIES: 
8. What is the highest level of activity you can participate in on a regular basis? 
Very strenuous activities like jumping or pivoting as in basketball or soccer 
Strenuous activities like heavy physical work, skiing or tennis 
Moderate activities like moderate physical work, running or jogging 
Light activities like walking, housework or yard work 
Unable to perform any of the above activities due to knee 
9. How does your knee affect your ability to: 










a. Go up stairs      
b. Go down stairs      
c. Kneel on the front of your 
knee 
     
d. Squat      
e. Sit with your knee bent      
f. Rise from a chair      
g. Run straight ahead      
h. Jump and land on your 
involved leg 
     
i. Stop and start quickly      
 
FUNCTION: 
10. How would you rate the function of your knee on a scale of 0 to 10 with 10 being normal, 
excellent function and 0 being the inability to perform any of your usual daily activities 
which may include sports?   
 
FUNCTION PRIOR TO YOUR KNEE INJURY: 
Cannot perform daily activities       No limitation daily activities 
 0  1  2  3  4  5  6  7  8  9 10    
 
              
 
CURRENT FUNCTION OF YOUR KNEE: 
Cannot perform daily activities       No limitation daily activities 
  
 0  1  2  3  4  5  6  7  8  9 10    
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Subject:Initial Study Approval for [ HUM00125211 ] 
  
SUBMISSION INFORMATION: 
Study Title: Outcomes of Femoral Nerve Block in ACL Reconstruction  
Full Study Title (if applicable): Outcomes of Femoral Nerve Block in ACL Reconstruction  
Study eResearch ID: HUM00125211  
Date of this Notification from IRB:2/7/2017  
Review: Expedited   
Initial IRB Approval Date: 2/7/2017  
Current IRB Approval Period:2/7/2017 - 2/6/2018  
Expiration Date: Approval for this expires at 11:59 p.m. on 2/6/2018  
UM Federalwide Assurance (FWA): FWA00004969 (For the current FWA expiration 
date, please visit the UM HRPP Webpage)  
OHRP IRB Registration Number(s): IRB00000248  
  
Please check with the HIPAA officer of your institution to ensure all HIPAA 
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Approved Risk Level(s):  
Name Risk Level 
HUM00125211 





NOTICE OF IRB APPROVAL AND CONDITIONS: 
The IRB Flint has reviewed and approved the study referenced above. The IRB 
determined that the proposed research conforms with applicable guidelines, State 
and federal regulations, and the University of Michigan's Federalwide Assurance 
(FWA) with the Department of Health and Human Services (HHS). You must 
conduct this study in accordance with the description and information provided in 
the approved application and associated documents.  
  
APPROVAL PERIOD AND EXPIRATION: 
The approval period for this study is listed above. Please note the expiration date. 
If the approval lapses, you may not conduct work on this study until appropriate 
approval has been re-established, except as necessary to eliminate apparent 
immediate hazards to research subjects. Should the latter occur, you must notify 
the IRB Office as soon as possible. 
IMPORTANT REMINDERS AND ADDITIONAL INFORMATION FOR INVESTIGATORS  
APPROVED STUDY DOCUMENTS: 
You must use any date-stamped versions of recruitment materials and informed 
consent documents available in the eResearch workspace (referenced above). 
Date-stamped materials are available in the “Currently Approved Documents” 
section on the “Documents” tab. 
RENEWAL/TERMINATION: 
At least two months prior to the expiration date, you should submit a continuing 
review application either to renew or terminate the study. Failure to allow 
sufficient time for IRB review may result in a lapse of approval that may also 
affect any funding associated with the study. 
AMENDMENTS: 
All proposed changes to the study (e.g., personnel, procedures, or documents), 
must be approved in advance by the IRB through the amendment process, except 
as necessary to eliminate apparent immediate hazards to research subjects. 
Should the latter occur, you must notify the IRB Office as soon as possible. 
AEs/ORIOs: 
You must inform the IRB of all unanticipated events, adverse events (AEs), and 
other reportable information and occurrences (ORIOs). These include but are not 
limited to events and/or information that may have physical, psychological, social, 
legal, or economic impact on the research subjects or other. 
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Investigators and research staff are responsible for reporting information 
concerning the approved research to the IRB in a timely fashion, understanding 
and adhering to the reporting guidance ( 
http://medicine.umich.edu/medschool/research/office-research/institutional-
review-boards/guidance/adverse-events-aes-other-reportable-information-and-
occurrences-orios-and-other-required-reporting), and not implementing any 
changes to the research without IRB approval of the change via an amendment 
submission. When changes are necessary to eliminate apparent immediate 
hazards to the subject, implement the change and report via an ORIO and/or 
amendment submission within 7 days after the action is taken. This includes all 
information with the potential to impact the risk or benefit assessments of the 
research. 
SUBMITTING VIA eRESEARCH: 
You can access the online forms for continuing review, amendments, and 
AEs/ORIOs in the eResearch workspace for this approved study (referenced 
above). 
MORE INFORMATION: 
You can find additional information about UM’s Human Research Protection 
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